Amanda Wait
@amandawait
Experienced antitrust adviser to deal makers; Partner at DLA Piper; all views are my own
ID: 127279315
http://www.linkedin.com/in/amandawait 28-03-2010 17:43:56
301 Tweet
327 Followers
181 Following
Andrew Eklund, Amanda Wait and Mark Angland discuss the Federal Trade Commission’s announcement of two enforcement actions for failing to provide the Commission with notice of acquisitions that satisfied premerger notification. ow.ly/TKsE50Hk62E
Prof. Alvaro Bedoya's confirmation to FTC creates a Democratic majority and paves the way for continued expansion of potential theories of harm in both #antitrust and #consumerprotection investigations. Read more from me and Mark Angland in Norton Rose Fulbright's antitrust practice.
Some say the FTC's proposed noncompete rule doesn't apply to nonprofits. Norton Rose Fulbright's Abraham Chang and I say: It's not that simple ... especially for healthcare companies!
The top 10 global antitrust trends in merger control, investigations, and litigation in 2023 from Norton Rose Fulbright's #antitrust team are out: nortonrosefulbright.com/en/knowledge/p…
"She's very practical, very responsive and is thorough." Recommendations by clients and co-counsel are the highest honor a lawyer can receive. Thank you Chambers and Partners for ranking me as a leading #antitrust lawyer in Washington, DC.
Hot off the presses: FTC and DOJ proposed new HSR filing rules today with significant timing and burden implications for merging parties. Gerald A. Stein, Andrew Eklund, and I provide our quick take.
#privateequity buyers of NY #healthcare providers: Here's what you need to know about the new notification requirements. I break it down with Leslie Rebnord, Purvi Maniar, and Andrew Roth of Norton Rose Fulbright in Law360. law360.com/competition/ar…
As promised yesterday, here's more analysis by Norton Rose Fulbright's US Antitrust team after reviewing more than 50 pages and 100 footnotes!